Carregant...

The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib

The ubiquitin–proteasome system has become a promising molecular target in cancer therapy due to its critical role in cellular protein degradation, interaction with cell cycle and apoptosis regulation, and unique mechanism of action. Bortezomib (PS-341) is a potent and specific reversible proteasome...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Milano, A, Perri, F, Caponigro, F
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886336/
https://ncbi.nlm.nih.gov/pubmed/20616904
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!